List of largest biotechnology companies

From Infogalactic: the planetary knowledge core
Jump to: navigation, search

A biotechnology company is a company whose products or services primarily use biotechnology methods for their production, design or delivery. The United Nations Convention on Biological Diversity defines 'biotechnology' as: "Any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use."[1] In other words, biotechology can be defined as the mere application of technical advances in life science to develop commercial products. Today, no comprehensive global database of biotech companies is available online, despite the fact that a free and open access project was launched in late 2014.[2]

Independent biotechnology companies

  • The following is a list of the top 25 independent biotechnology companies listed on a stock exchange ranked by Market Capitalization as of June 2015 (Q3 2015).
  • Note that it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups.
Rank Change Company Country Highest Market Cap ever (historical)(USD billions) Market Cap in 2015 (USD billions)[3] Market Cap in 2014 (USD billions)[4] Market Cap in 2013 (USD billions)
1 Steady Johnson & Johnson  United States 306.4
September 2014
284.2 277.8 258.3
2 Steady Roche   Switzerland 263.6
February 2014
234.7 258.5 240.3
3 Steady Novartis   Switzerland 275.2
July 2015
206.1 229.8 195.0
4 Steady Pfizer  United States 310.5
July 2000
199.3 205.4 196.0
5 Steady Novo Nordisk  Denmark 153.8
June 2015
153.9 125.4 19.6
6 Steady Gilead Sciences  United States 179.6
June 2013
145.8 109.0 78.4
7 Steady Merck  United States 178.9
January 2015
147.6 166.9 146.5
8 Increase Allergan, Plc  United States 122.6
July 2015
123.2 38.2 15.0
9 Increase Amgen  United States 130.6
December 2014
122.5 93.1 78.7
10 Increase Bristol-Myers Squibb  United States 115.3
May 2015
114.8 97.6 87.2
11 Steady Bayer  Germany 129
March 2015
103.2 113.2 117.4
12 Decrease Sanofi  France 151.3
September 2014
111.8 138.1 142.0
13 Increase GlaxoSmithKline  United Kingdom 174.9
May 2006
97.6 128.9 129.6
14 Decrease Eli Lilly & Co  United States 122.6
August 2000
93.4 76.6 57.0
15 Decrease AbbVie  United States 112.2
June 2015
96.8 104.1 83.8
16 Decrease Celgene  United States 102.9
March 2015
94.1 89.5 69.2
17 Steady AstraZeneca  United Kingdom 102.9
October 2006
85.8 88.9 74.6
18 Steady Biogen Idec  United States 111.7
March 2015
68.3 79.7 66.1
19 Increase Abbott Laboratories  United States 74.8
July 2015
67.0 67.9 59.3
20 Increase Regeneron Pharmaceuticals Inc  United States 56.5
December 2015
56.5 42.0 27.4
21 Increase Teva Pharmaceutical  Israel 58.9
April 2010
55.9 49.0 37.8
22 Increase Alexion Pharmaceuticals  United States 43.1
June 2015
43.0 36.8 26.2
23 Steady Shire Pharmaceuticals  Ireland 52.4
October 2014
41.0 42.4 28.1
24 Decrease Valeant Pharmaceuticals  Canada 90.0
August 2015
34.9 47.9 39.1
25 Steady Mylan  United States 37.2
April 2015
26.6 21.2 16.1

References

External links